LCT Announcement
[ Follow-Ups ]
[ Post Followup ]
[ The Islet Foundation Public Message Forum ]
Posted by Frank Cz. on 23:39:30 2010/06/09
Cell implant company Living Cell Technologies Limited today announced it has started working from this week on an animal-derived therapeutics project with the New Zealand government's investment promotion agency, Investment New Zealand (a division of New Zealand Trade & Enterprise).
--------------------------------------------------------------------------------
LCT breeds unique biocertified pathogen-free pigs derived from remote sub-Antarctic islands for its cell based products, including DIABECELL® for the treatment of insulin dependent diabetes and NTCELL for neurodegenerative diseases. LCT's pig herds are free from viruses, bacteria and parasites and do not secrete porcine endogenous retroviruses.
The project with Investment New Zealand was developed to jointly identify market opportunities for high quality by-products derived from the Company's unused porcine tissue for additional medical applications.
Dr Paul Tan, Chief Executive Officer for LCT, said, "We are pleased to work with the New Zealand government in an area of common interest that fosters economic development for New Zealand and enhances the value of LCT's pigs."
Given New Zealand's premier animal health status, Investment New Zealand aims to position New Zealand as the global location of choice for companies developing human therapeutics and biologics that require high quality animal-derived materials.
Follow Ups:
Post a Followup
[ Follow Ups ]
[ Post Followup ]
[ The Islet Foundation Public Message Forum ]